Cargando…

Markers of Subclinical Cardiovascular Disease in Patients with Adrenal Incidentaloma

Due to the growing availability of imaging examinations the percentage of patients with incidentally diagnosed adrenal tumors has increased. The vast majority of these lesions are benign, non-functioning adenomas, although according to various estimates even up to 30%–50% of patients with adrenal in...

Descripción completa

Detalles Bibliográficos
Autores principales: Szychlińska, Magdalena, Baranowska-Jurkun, Angelika, Matuszewski, Wojciech, Wołos-Kłosowicz, Katarzyna, Bandurska-Stankiewicz, Elżbieta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074127/
https://www.ncbi.nlm.nih.gov/pubmed/32050625
http://dx.doi.org/10.3390/medicina56020069
_version_ 1783506766117470208
author Szychlińska, Magdalena
Baranowska-Jurkun, Angelika
Matuszewski, Wojciech
Wołos-Kłosowicz, Katarzyna
Bandurska-Stankiewicz, Elżbieta
author_facet Szychlińska, Magdalena
Baranowska-Jurkun, Angelika
Matuszewski, Wojciech
Wołos-Kłosowicz, Katarzyna
Bandurska-Stankiewicz, Elżbieta
author_sort Szychlińska, Magdalena
collection PubMed
description Due to the growing availability of imaging examinations the percentage of patients with incidentally diagnosed adrenal tumors has increased. The vast majority of these lesions are benign, non-functioning adenomas, although according to various estimates even up to 30%–50% of patients with adrenal incidentaloma may present biochemical hypercortisolemia, without typical clinical features of Cushing’s syndrome. Adrenal adenomas secreting small amounts of glucocorticoids may cause morphological and functional changes in the myocardium and blood vessels. Early stages of cardiovascular remodeling may be observed among asymptomatic patients with adrenal adenoma. Vascular changes precede the development of cardiovascular diseases and can increase morbidity and mortality in patients with adrenal incidentaloma. This risk may result not only from the traditional risk factors. Seemingly hormonally inactive adrenal tumors can indeed produce small amounts of glucocorticoids that have metabolic implications. Therefore, evaluation of patients with incidental adrenal findings presenting with subclinical cardiovascular disease seems of particular importance.
format Online
Article
Text
id pubmed-7074127
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70741272020-03-19 Markers of Subclinical Cardiovascular Disease in Patients with Adrenal Incidentaloma Szychlińska, Magdalena Baranowska-Jurkun, Angelika Matuszewski, Wojciech Wołos-Kłosowicz, Katarzyna Bandurska-Stankiewicz, Elżbieta Medicina (Kaunas) Review Due to the growing availability of imaging examinations the percentage of patients with incidentally diagnosed adrenal tumors has increased. The vast majority of these lesions are benign, non-functioning adenomas, although according to various estimates even up to 30%–50% of patients with adrenal incidentaloma may present biochemical hypercortisolemia, without typical clinical features of Cushing’s syndrome. Adrenal adenomas secreting small amounts of glucocorticoids may cause morphological and functional changes in the myocardium and blood vessels. Early stages of cardiovascular remodeling may be observed among asymptomatic patients with adrenal adenoma. Vascular changes precede the development of cardiovascular diseases and can increase morbidity and mortality in patients with adrenal incidentaloma. This risk may result not only from the traditional risk factors. Seemingly hormonally inactive adrenal tumors can indeed produce small amounts of glucocorticoids that have metabolic implications. Therefore, evaluation of patients with incidental adrenal findings presenting with subclinical cardiovascular disease seems of particular importance. MDPI 2020-02-10 /pmc/articles/PMC7074127/ /pubmed/32050625 http://dx.doi.org/10.3390/medicina56020069 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Szychlińska, Magdalena
Baranowska-Jurkun, Angelika
Matuszewski, Wojciech
Wołos-Kłosowicz, Katarzyna
Bandurska-Stankiewicz, Elżbieta
Markers of Subclinical Cardiovascular Disease in Patients with Adrenal Incidentaloma
title Markers of Subclinical Cardiovascular Disease in Patients with Adrenal Incidentaloma
title_full Markers of Subclinical Cardiovascular Disease in Patients with Adrenal Incidentaloma
title_fullStr Markers of Subclinical Cardiovascular Disease in Patients with Adrenal Incidentaloma
title_full_unstemmed Markers of Subclinical Cardiovascular Disease in Patients with Adrenal Incidentaloma
title_short Markers of Subclinical Cardiovascular Disease in Patients with Adrenal Incidentaloma
title_sort markers of subclinical cardiovascular disease in patients with adrenal incidentaloma
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074127/
https://www.ncbi.nlm.nih.gov/pubmed/32050625
http://dx.doi.org/10.3390/medicina56020069
work_keys_str_mv AT szychlinskamagdalena markersofsubclinicalcardiovasculardiseaseinpatientswithadrenalincidentaloma
AT baranowskajurkunangelika markersofsubclinicalcardiovasculardiseaseinpatientswithadrenalincidentaloma
AT matuszewskiwojciech markersofsubclinicalcardiovasculardiseaseinpatientswithadrenalincidentaloma
AT wołoskłosowiczkatarzyna markersofsubclinicalcardiovasculardiseaseinpatientswithadrenalincidentaloma
AT bandurskastankiewiczelzbieta markersofsubclinicalcardiovasculardiseaseinpatientswithadrenalincidentaloma